This site displays a prototype of a “Web 2.0” version of the daily Federal Register. It is not an official legal edition of the Federal Register, and does not replace the official print version or the official electronic version on GPO’s govinfo.gov.
The documents posted on this site are XML renditions of published Federal Register documents. Each document posted on the site includes a link to the corresponding official PDF file on govinfo.gov. This prototype edition of the daily Federal Register on FederalRegister.gov will remain an unofficial informational resource until the Administrative Committee of the Federal Register (ACFR) issues a regulation granting it official legal status. For complete information about, and access to, our official publications and services, go to About the Federal Register on NARA's archives.gov.
The OFR/GPO partnership is committed to presenting accurate and reliable regulatory information on FederalRegister.gov with the objective of establishing the XML-based Federal Register as an ACFR-sanctioned publication in the future. While every effort has been made to ensure that the material on FederalRegister.gov is accurately displayed, consistent with the official SGML-based PDF version on govinfo.gov, those relying on it for legal research should verify their results against an official edition of the Federal Register. Until the ACFR grants it official status, the XML rendition of the daily Federal Register on FederalRegister.gov does not provide legal notice to the public or judicial notice to the courts.
Food and Drug Administration, HHS.
The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995 (the PRA).
Fax written comments on the collection of information by June 14, 2010.
To ensure that comments on the information collection are received, OMB recommends that written comments be faxed to the Office of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer, FAX: 202-395-7285, or e-mailed to email@example.com. All comments should be identified with the OMB control number 0910-0025. Also include the FDA docket number found in brackets in the heading of this document.Start Further Info
FOR FURTHER INFORMATION CONTACT:
Daniel Gittleson, Office of Information Management, Food and Drug Administration, 1350 Piccard Dr., PI50-400B, Rockville, MD 20850, 301-796-5156, email: Daniel.Gittleson@fda.hhs.gov.End Further Info End Preamble Start Supplemental Information
In compliance with 44 U.S.C. 3507, FDA has submitted the following proposed collection of information to OMB for review and clearance.
Reporting and Recordkeeping Requirements and Availability of Sample Electronic Products for Manufacturers and Distributors of Electronic Products (OMB Control Number 0910-0025)—Extension
Under sections 532 through 542 of the Federal Food, Drug, and Cosmetic Act (the act) (21 U.S.C. 360ii through 360ss), FDA has the responsibility to protect the public from unnecessary exposure of radiation from electronic products. The regulations issued under these authorities are listed in title 21 of the Code of Federal Regulations, chapter I, subpart J, parts 1000 through 1050 (parts 1002 through 1050).
Section 532 of the act directs the Secretary of the Department of Health and Human Services (the Secretary), to establish and carry out an electronic product radiation control program, including the development, issuance, and administration of performance standards to control the emission of electronic product radiation from electronic products. The program is designed to protect the public health and safety from electronic radiation, and the act authorizes the Secretary to procure (by negotiation or otherwise) electronic products for research and testing purposes and to sell or otherwise dispose of such products. Section 534(g) of the act directs the Secretary to review and evaluate industry testing programs on a continuing basis; and section 535(e) and (f) of the act directs the Secretary to immediately notify manufacturers of, and ensure correction of, radiation defects or noncompliances with performance standards. Section 537(b) of the act contains the authority to require manufacturers of electronic products to establish and maintain records (including testing records), make reports, and provide information to determine whether the manufacturer has acted in compliance.
The regulations under parts 1002 through 1010 specify reports to be provided by manufacturers and distributors to FDA and records to be maintained in the event of an investigation of a safety concern or a product recall.
FDA conducts laboratory compliance testing of products covered by regulations for product standards in parts 1020, 1030, 1040, and 1050.
FDA details product-specific performance standards that specify information to be supplied with the product or require specific reports. The information collections are either specifically called for in the act or were developed to aid the Agency in performing its obligations under the act. The data reported to FDA and the records maintained are used by FDA and the industry to make decisions and take actions that protect the public from radiation hazards presented by electronic products. This information refers to the identification of, location of, operational characteristics of, quality assurance programs for, and problem identification and correction of electronic products. The data provided to users and others are intended to encourage actions to reduce or eliminate radiation exposures.
FDA uses the following forms to aid respondents in the submission of information for this information collection:
- FDA Form 2579 “Report of Assembly of a Diagnostic X-Ray System”
- FDA Form 2767 “Notice of Availability of Sample Electronic Product”
- FDA Form 2877 “Declaration for Imported Electronic Products Subject to Radiation Control Standards”
- FDA Form 3649 “Accidental Radiation Occurrence (ARO)”
- FDA Form 3626 “A Guide for the Submission of Initial Reports on Diagnostic X-Ray Systems and Their Major Components”
- FDA Form 3627 “Diagnostic X-Ray CT Products Radiation Safety Report”
- FDA Form 3628 “General Annual Report (Includes Medical, Analytical, and Industrial X-Ray Products Annual Report)”
- FDA Form 3629 “Abbreviated Report”
- FDA Form 3630 “Guide for Preparing Product Reports on Sunlamps and Sunlamp Products”
- FDA Form 3631 “Guide for Preparing Annual Reports on Radiation Safety Testing of Sunlamps and Sunlamp Products”
- FDA Form 3632 “Guide for Preparing Product Reports on Lasers and Products Containing Lasers”
- FDA Form 3633 “General Variance Request”
- FDA Form 3634 “Television Products Annual Report”
- FDA Form 3635 “Laser Light Show Notification”
- FDA Form 3636 “Guide for Preparing Annual Reports on Radiation Safety Testing of Laser and Laser Light Show Products”
- FDA Form 3637 “Laser Original Equipment Manufacturer (OEM) Report”
- FDA Form 3638 “Guide for Filing Annual Reports for X-Ray Components and Systems”Start Printed Page 26965
- FDA Form 3639 “Guidance for the Submission of Cabinet X-Ray System Reports Pursuant to 21 CFR 1020.40”
- FDA Form 3640 “Reporting Guide for Laser Light Shows and Displays”
- FDA Form 3147 “Application for a Variance From 21 CFR 1040.11(c) for a Laser Light Show, Display, or Device”
- FDA Form 3641 “Cabinet X-Ray Annual Report”
- FDA Form 3642 “General Correspondence”
- FDA Form 3643 “Microwave Oven Products Annual Report”
- FDA Form 3644 “Guide for Preparing Product Reports for Ultrasonic Therapy Products”
- FDA Form 3645 “Guide for Preparing Annual Reports for Ultrasonic Therapy Products”
- FDA Form 3646 “Mercury Vapor Lamp Products Radiation Safety Report”
- FDA Form 3647 “Guide for Preparing Annual Reports on Radiation Safety Testing of Mercury Vapor Lamps”
- FDA Form 3659 “Reporting and Compliance Guide for Television Products”
- FDA Form 3660 “Guidance for Preparing Reports on Radiation Safety of Microwave Ovens”
- FDA Form 3661 “Guide for the Submission of an Abbreviated Report on X-Ray Tables, Cradles, Film Changers, or Cassette Holders Intended for Diagnostic Use”
- FDA Form 3662 “Guide for Submission of an Abbreviated Radiation Safety Report on Cephalometric Devices Intended for Diagnostic Use”
- FDA Form 3663 “Abbreviated Reports on Radiation Safety for Microwave Products (Other than Microwave Ovens)”
- FDA Form 3801 “Guide for Preparing Initial Reports and Model Change Reports on Medical Ultraviolet Lamps and Products Containing Such Lamps”
The most likely respondents to this information collection will be electronic product and x-ray manufacturers, importers, and assemblers.
In the Federal Register of February 26, 2010 (75 FR 8963), FDA published a 60-day notice requesting public comment on the proposed collection of information. No comments were received.
FDA estimates the burden of this collection of information as follows:
|21 CFR Section/Part||FDA Form No.||No. of Respondents||Annual Frequency per Response||Total Annual Responses||Hours per Response||Total Hours|
|1002.10||3626—Diagnostic X-Ray 3627—CT X-Ray 3639—Cabinet X-Ray 3632—Laser 3640—Laser Light Show 3630—Sunlamp 3646—Mercury Vapor Lamp 3644—Ultrasonic Therapy 3659—TV 3660—Microwave Oven 3801—UV Lamps||1,000||1.2||1,200||24||28,800|
|1002.12||3629—General Abbreviated Report 3661—X-Ray Tables, etc. 3662—Cephalometric Device 3663—non-Oven Microwave Product||50||1||50||5||250|
|1002.13||3628—General 3634—TV 3638—Diagnostic X-Ray 3641—Cabinet X-Ray 3643—Microwave Oven 3636—Laser 3631—Sunlamp 3647—Mercury Vapor Lamp 3645—Ultrasonic Therapy||1,000||1||1,000||18||18,000|
|1002.50(a) and 1002.51||3642—General Correspondence||10||0.5||5||1||5|
|Start Printed Page 26966|
|1010.4(b)||3633—General Variance Request 3147—Laser Show Variance Request 3635—Laser Show Notification||160||0.3||48||1.2||58|
|1010.5(c) and (d)||N/A||4||1||4||22||88|
|1020.30(d), (d)(1), and (d)(2)||2579—Assembler Report||1,150||10.7||12,305||0.30||3,692|
|1020.30(h)(1) through (h)(4), 1020.32(a)(1) and (g)||N/A||200||1.33||266||35||9,310|
|1020.30(h)(5) and (h)(6) and 1020.32(j)(4)||N/A||20||5||100||18||1,800|
|1020.32(g), 1020.33(c), (d), (g)(4), (j)(3), and (j)(4)||N/A||9||1||9||40||360|
|1020.40(c)(9)(i) and (c)(9)(ii)||N/A||8||1||8||40||320|
|1030.10(c)(5)(i) through (c)(5)(iv)||N/A||41||1.6||66||20||1,320|
|1030.10(c)(6)(iii) and (c)(6)(iv)||N/A||1||1||1||1||1|
|1040.10(h)(1)(i) through (h)(1)(vi)||N/A||805||1||805||8||6,440|
|1040.10(h)(2)(i) and (h)(2)(ii)||N/A||100||1||100||8||800|
|1040.20(d)(1)(ii) through (d)(1)(vi), (e)(1), and (e)(2)||N/A||110||1||110||10||1,100|
|1050.10(d)(1) through (d)(4) and (f)(1) through (f)(2)(iii)||N/A||10||1||10||56||560|
|Total Annual Reporting Burden||88,435|
|1 There are no capital costs or operating and maintenance costs associated with this collection of information|
|21 CFR Section||No. of Recordkeepers||Annual Frequency of Recordkeeping||Total Annual Records||Hours per Record||Total Hours|
|1002.30 and 1002.31(a)||1,150||1,655.5||1,903,825||0.12||228,459|
|1002.40 and 1002.41||2,950||49.2||145,140||0.05||7,257|
|1 There are no capital costs or operating and maintenance costs associated with this collection of information.|
The burden estimates were derived by consultation with FDA and industry personnel, and are based on actual data collected from industry. An evaluation of the type and scope of information requested was also used to derive some time estimates. For example, disclosure information primarily requires time only to update and maintain existing manuals. Initial development of manuals has been performed except for new firms entering the industry.
The following information collection requirements are not subject to review by OMB because they do not constitute a “collection of information” under the PRA: Sections 1002.31(c); 1003.10(a), (b), and (c); 1003.11(a)(3) and (b); 1003.20(a) through (h); 1003.21(a) through (d); 1003.22(a) and (b); 1003.30(a) and (b); 1003.31(a) and (b); 1004.2(a) through (i); 1004.3(a) through (i); 1004.4(a) through (h); 1005.21(a) through (c); and 1005.22(b). These requirements apply to the collection of information during the conduct of general investigations or audits (5 CFR 1320.4(b)).
The following labeling requirements are also not subject to review under the PRA because they are a public disclosure of information originally supplied by the Federal Government to the recipient for the purpose of disclosure to the public (5 CFR 1320.3(c)(2)): Sections 1020.10(c)(4), 1030.10(c)(6), 1040.10(g), 1040.30(c)(1), and 1050.10(d)(1).Start Signature
Dated: May 7, 2010.
Acting Assistant Commissioner for Policy.
[FR Doc. 2010-11396 Filed 5-12-10; 8:45 am]
BILLING CODE 4160-01-S